CLYMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Climb Bio, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$9.73−0.09 (-0.92%)
Close on Oct 19, 2026
- Market cap
- $740.98M
- P/E (TTM)
- –
- Dividend yield
- –
Climb Bio statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Climb Bio | Industry median |
|---|---|---|
| Market Cap | $558.86M | $166.30M |
| Enterprise Value | $375.73M | $88.19M |
| PB Ratio | 2.33 | 2.03 |
| P/TBV Ratio | 2.33 | 2.29 |
Income (trailing twelve months)
| Measure | Climb Bio | Industry median |
|---|---|---|
| Operating Income | -$64.76M | -$21.40M |
| Net Income | -$57.62M | -$22.46M |
| EBITDA | -$64.63M | -$16.91M |
| EPS (Diluted) | -$0.83 | -$0.83 |
Returns
| Measure | Climb Bio | Industry median |
|---|---|---|
| Return on Equity (ROE) | -27.1% | -53.2% |
| Return on Assets (ROA) | -26.3% | -40.9% |
| Return on Invested Capital (ROIC) | -65.0% | -32.4% |
| Return on Capital Employed (ROCE) | -26.9% | -38.1% |
Balance sheet
| Measure | Climb Bio | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $183.12M | $61.43M |
| Net Cash (Debt) | $183.12M | $15.35M |
| Net Cash Per Share | $3.19 | $0.66 |
| Equity (Book Value) | $239.55M | $49.09M |
| Book Value Per Share | $4.17 | $1.37 |
| Tangible Book Value | $239.55M | $23.52M |
| Working Capital | $180.70M | $76.81M |
Financial position
| Measure | Climb Bio | Industry median |
|---|---|---|
| Current Ratio | 31.45 | 3.34 |
| Quick Ratio | 30.86 | 2.44 |
Cash flow (trailing twelve months)
| Measure | Climb Bio | Industry median |
|---|---|---|
| Operating Cash Flow | -$52.70M | -$12.35M |
Efficiency
| Measure | Climb Bio | Industry median |
|---|---|---|
| Profits Per Employee | -$2.06M | -$703.34K |
| Employee Count | 28 | 74 |
Dividends and yields
| Measure | Climb Bio | Industry median |
|---|---|---|
| Earnings Yield | -10.3% | -23.3% |
Shares
| Measure | Climb Bio | Industry median |
|---|---|---|
| Shares Outstanding | 57,436,300 | 58,127,000 |
| Shares Change (YoY) | 4.13% | 10.9% |
| Shares Change (QoQ) | 20.2% | 0.54% |
| Float | 30,824,100 | 49,136,700 |
| Shares Held by Insiders | 46.3% | 11.6% |
| Shares Held by Institutions | 98.1% | 59.4% |
Scores
| Measure | Climb Bio | Industry median |
|---|---|---|
| Altman Z-Score | 47.91 | -0.22 |
| Piotroski F-Score | 2 | 4 |
Calculated by StockData from Climb Bio's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.